The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma
- PMID: 15234033
- DOI: 10.1016/j.ijrobp.2004.01.040
The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma
Abstract
Purpose: The role of neck dissection after radiation therapy ([RT] with or without chemotherapy) for regionally advanced head and neck cancer is controversial. As much as 50% of residual lymphadenopathy after radiation has no viable tumor cells present on histopathologic analysis. [(18)F] fluorodeoxyglucose positron emission tomography (FDG PET) imaging can detect metabolically active cancer. This study examines the ability of post-RT FDG PET imaging to predict the tumor status of residual lymphadenopathy after nonsurgical management of regionally advanced neck disease.
Methods and material: From February 2000 to October 2002, 41 patients were treated definitively by radiation (with or without chemotherapy) and underwent FDG PET and computed tomography (CT) imaging after treatment to assess response. Patients with negative CT and FDG PET scans were observed and did not undergo neck dissection. Patients with radiographically persistent lymphadenopathy underwent either neck dissection or fine-needle aspiration of the lymph nodes using ultrasound guidance. The results of the FDG PET scans were correlated with the pathologic findings.
Results: Twelve patients with persistent lymphadenopathy underwent either neck dissection or fine-needle aspiration. Four of the 12 were found to have viable residual tumor in the cervical lymph nodes. The pathology did not correlate with the size of the lymph nodes in the pre-RT or post-RT CT studies. However, the pathology correlated strongly with the post-RT FDG PET studies. All patients with a negative post-RT FDG PET or those with a maximum standardized uptake value (SUV(max)) of less than 3.0 in the post-RT FDG PET were found to be free of residual viable tumor. Using an SUV(max) of less than 3.0 as the criterion for a negative FDG PET study, the negative predictive value was 100% and the positive predictive value was 80%.
Conclusions: A negative post-RT FDG PET scan is very predictive of negative pathology in neck dissection or fine-needle aspiration even with large residual lymphadenopathy. Therefore, if the post-RT FDG PET scan is negative, neck dissection might not be required for regional control. A prospective study with longer follow-up and greater patient numbers is needed to determine whether a policy of deferring neck dissection based on a negative FDG PET is supported.
Similar articles
-
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):991-9. doi: 10.1016/j.ijrobp.2005.03.066. Epub 2005 Aug 15. Int J Radiat Oncol Biol Phys. 2005. PMID: 16099601
-
Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.Am J Clin Oncol. 2007 Jun;30(3):264-70. doi: 10.1097/01.coc.0000257611.65290.aa. Am J Clin Oncol. 2007. PMID: 17551303
-
Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):694-7. doi: 10.1016/S0360-3016(03)01625-0. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967422
-
PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.J Nucl Med. 2004 Jan;45(1):56-68. J Nucl Med. 2004. PMID: 14734674 Review.
-
Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.Acta Otorhinolaryngol Belg. 2002;56(1):77-82. Acta Otorhinolaryngol Belg. 2002. PMID: 11894635 Review.
Cited by
-
Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):472-9. doi: 10.1016/j.ijrobp.2014.11.002. Epub 2015 Jan 30. Int J Radiat Oncol Biol Phys. 2015. PMID: 25680593 Free PMC article.
-
Proton Therapy for Locally Advanced Oropharyngeal Cancer: Initial Clinical Experience at the University of Washington.Int J Part Ther. 2020 Winter;6(3):1-12. doi: 10.14338/IJPT-19-00053.1. Epub 2019 Dec 19. Int J Part Ther. 2020. PMID: 32582809 Free PMC article.
-
Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.AJNR Am J Neuroradiol. 2010 Apr;31(4):598-604. doi: 10.3174/ajnr.A1760. Epub 2009 Nov 12. AJNR Am J Neuroradiol. 2010. PMID: 19910448 Free PMC article.
-
Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):656-62. doi: 10.1007/s00259-010-1670-3. Epub 2010 Dec 16. Eur J Nucl Med Mol Imaging. 2011. PMID: 21161213
-
Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse.Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1783-93. doi: 10.1007/s00259-009-1180-3. Epub 2009 Jun 4. Eur J Nucl Med Mol Imaging. 2009. PMID: 19495747 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials